Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
28,736,767
-
Total 13F shares
-
4,007,551
-
Share change
-
-458,302
-
Total reported value
-
$521,259,956
-
Price per share
-
$130.06
-
Number of holders
-
88
-
Value change
-
-$59,044,357
-
Number of buys
-
43
-
Number of sells
-
43
Institutional Holders of GeneDx Holdings Corp. - Common Stock (WGS) as of Q4 2025
As of 31 Dec 2025,
GeneDx Holdings Corp. - Common Stock (WGS) was held by
88 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,007,551 shares.
The largest 10 holders included
VANGUARD GROUP INC, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, Sumitomo Mitsui Trust Group, Inc., JENNISON ASSOCIATES LLC, Assenagon Asset Management S.A., MASSACHUSETTS FINANCIAL SERVICES CO /MA/, UBS Group AG, Palisades Investment Partners, LLC, PRINCIPAL FINANCIAL GROUP INC, and ROYCE & ASSOCIATES LP.
This page lists
94
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.